Seelos Therapeutics (STU:NXE) OCF Yield %: 0.00 (As of Jul. 12, 2026)


STU:NXE Seelos Therapeutics Inc STU:NXE
16 GF Score
Price €339.84
View Full Analysis

What is Seelos Therapeutics OCF Yield %?

Seelos Therapeutics STU:NXE 16 OCF Yield % is 0.00 as of Jul. 12, 2026. GuruFocus rates STU:NXE with a GF Score™ of 16/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Seelos Therapeutics's Trailing 12-Month Cash Flow from Operations is €-12.31 Mil, and Market Cap is €0.00 Mil. Therefore, Seelos Therapeutics's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Seelos Therapeutics's OCF Yield % or its related term are showing as below:


STU:NXE's OCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -8.26
* Ranked among companies with meaningful OCF Yield % only.

Seelos Therapeutics's OCF Margin % for the quarter that ended in Jun. 2024 was %.

Seelos Therapeutics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Seelos Therapeutics OCF Yield % Related Terms

Seelos Therapeutics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Seelos Therapeutics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seelos Therapeutics OCF Yield % Chart

Seelos Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -52.13 -26.43 -28.76 -83.74 -83.79

Seelos Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.15 -79.96 -26.78 -42.24 -5.11
STU:NXE
16GF Score
Seelos Therapeutics Inc STU:NXE
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seelos Therapeutics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Seelos Therapeutics's OCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-21.927 / 26.16768
=-83.79%

Seelos Therapeutics's annualized OCF Yield % for the quarter that ended in Jun. 2024 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.903 * 4 / 70.68672
=-5.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Seelos Therapeutics (STU:NXE) has a OCF Yield % of 0.00 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Seelos Therapeutics and its competitors.
Is Seelos Therapeutics' OCF Yield % too high?
Seelos Therapeutics' current OCF Yield % is 0.00. Overall, Seelos Therapeutics has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Seelos Therapeutics' OCF Yield % compare to NTBLQ and EFTR?
Seelos Therapeutics' OCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Seelos Therapeutics and its competitors. Seelos Therapeutics's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seelos Therapeutics stock overvalued right now?
Seelos Therapeutics (STU:NXE) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Seelos Therapeutics' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Seelos Therapeutics (STU:NXE), the current OCF Yield % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Seelos Therapeutics Business Description

Address 300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.
16GF Score

Get the complete analysis for STU:NXE

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€339.84
Price